Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
house dust mite allergen extract (University of Wisconsin–Madison)
- Development stage
- Phase 3
- Lead developer
- University of Wisconsin–Madison
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
House dust mite SLIT (sublingual immunotherapy) is an investigational allergen-based biologic developed by the University of Wisconsin-Madison for the treatment of allergic rhinitis and mild intermittent asthma. The therapy consists of a *Dermatophagoides farinae* (house dust mite) allergen extract administered sublingually. It works by modulating the immune system's response to dust mite allergens, specifically by increasing allergen-specific IgG4 levels and improving bronchial allergen thresholds, thereby reducing IgE-mediated hypersensitivity. In clinical trials, it has been evaluated in both high-dose (approximately 70 μg Der f 1) and low-dose (approximately 1 μg Der f 1) regimens to determine safety and efficacy in sensitized adults.
- Other names
- house dust mite SLITHDM-SLITDermatophagoides farinae allergen vaccine
02
Targets
sIgG4 (Allergen-specific immunoglobulin G4)TCR (T cell antigen receptor complex)
Beyond the preview
Go deeper on house dust mite allergen extract (University of Wisconsin–Madison).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on house dust mite allergen extract (University of Wisconsin–Madison).